Greetings,

On behalf of the International Neuromodulation Society, I am writing to invite you to submit your abstracts for our 13th World Congress, "Neuromodulation: Technology Changing Lives," that will take place on May 27 – June 1, 2017 at the Edinburgh International Conference Centre in Edinburgh, Scotland, UK. The the deadline to submit your work is January 9, 2017.

Two pre-conference days will focus on non-and less-invasive stimulation, as well as innovation and investment, followed by a three-and-a-half day scientific program. In line with the Society’s multidisciplinary educational mission, the congress offers a unique opportunity for valuable interactions with peers who, collectively, focus on every aspect of this growing field. We encourage you to contribute to this dynamic experience and submit your best original work.

Abstract categories encompass basic science, neural engineering, socioeconomics, and existing clinical therapies as well as potential future technologies. We welcome submissions on the following:

• The Spine (pain, spasticity, and movement disorders)
• The Brain (brain-computer interface, neurorehabilitation, movement disorders, epilepsy, consciousness and cognition)
• Headache
• The Peripheral Nervous System
• Cardiovascular Disorders
• Gastrointestinal Disorders
• Genitourinary Disorders
• Systemic Disease
• Non- and Less-Invasive Brain Stimulation
• Neuro-regeneration
• Neuroprosthetics and Neural Engineering

The INS Executive, Biennial Congress, and Education and CME Committees with members of the Neuromodulation Editorial Board will rigorously review each submission, and will select the strongest work for oral presentation, in addition to traditional poster presentation. The content of abstracts must promote improvements or quality in healthcare and not a specific proprietary business or commercial interest. Presentations must avoid commercialism and may not contain any commercial messaging. All accepted abstracts will be published on the Society’s website and in the online version of the INS journal, Neuromodulation: Technology at the Neural Interface.

We encourage you to enter the INS’s best abstract competition, in which the top five abstracts will be recognized for their quality, originality and ingenuity in basic or clinical science or neural-engineering. Primary authors will have an opportunity to enter the competition during the submission process. Award recipients will be notified in advance of the Congress, and will be recognized on stage during the INS General Assembly of Members on the 30th of May. In addition to this honor, the primary author recipients will be refunded their congress registration fees. To qualify for the competition, the primary author must be a current member of the INS and must have registered for the main congress.

The Congress registration and hotel booking system has launched, so we encourage you to register and make your hotel arrangements now. Please note that INS members will receive a special discounted registration rate, so now is the perfect opportunity to renew your membership or become a member of the INS.

To access the abstract submission system please visit the INS 2017 ScholarOne Abstracts site. Download the instructions for authors here. The abstract deadline is January 9, 2017.

We hope you and your colleagues will submit your best work and we look forward to seeing you in Edinburgh!

Dr. Timothy Deer
INS President and Congress Chair
inscongress@neuromodulation.com
www.neuromodulation.com/ins-congress
#INS2017

INS CME Mission Statement
The International Neuromodulation Society promotes improvement in patient health care by providing physicians and allied health care professionals with high quality, evidence-based educational activities focusing on advances in the field of neuromodulation; basic, translational and clinical research; new technology; and global health care. The overarching goals are to enhance learners’ knowledge, competence and performance to improve patient access, selection, safety and clinical outcomes.